Course Overview

Triple-negative breast cancer presents unique challenges and an urgent need for effective, personalized therapies. Treating advanced TNBC requires a deep understanding of:

  • Biomarker testing
  • Immunotherapy
  • PARP inhibitors
  • Antibody-drug conjugates

Join our free CME/CE webinar as we dive into recent advancements in TNBC treatment, presenting practical case studies and the latest data on managing treatment-related adverse events.

Credits available: 1.0 AMA, ANCC, or AAPA

Rita Nanda
Rita Nanda, MD

Director of Breast Oncology
Associate Professor of Medicine
University of Chicago